BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

812 related articles for article (PubMed ID: 7513927)

  • 1. Identification of overlapping class I and class II H-2d-restricted T cell determinants of influenza virus N1 neuraminidase that require infectious virus for presentation.
    Wysocka M; Eisenlohr LC; Otvos L; Horowitz D; Yewdell JW; Bennink JR; Hackett CJ
    Virology; 1994 May; 201(1):86-94. PubMed ID: 7513927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Class II MHC-restricted T cell determinants processed from either endosomes or the cytosol show similar requirements for host protein transport but different kinetics of presentation.
    Hackett CJ; Yewdell JW; Bennink JR; Wysocka M
    J Immunol; 1991 May; 146(9):2944-51. PubMed ID: 1673146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytolytic T lymphocytes from the BALB/c-H-2dm2 mouse recognize the vesicular stomatitis virus glycoprotein and are restricted by class II MHC antigens.
    Browning MJ; Huang AS; Reiss CS
    J Immunol; 1990 Aug; 145(3):985-94. PubMed ID: 1695651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The recognition of a viral antigenic moiety by class I MHC-restricted cytolytic T lymphocytes is limited by the availability of the endogenously processed antigen.
    Milligan GN; Morrison LA; Gorka J; Braciale VL; Braciale TJ
    J Immunol; 1990 Nov; 145(10):3188-93. PubMed ID: 1700000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fine specificity of murine class II-restricted T cell clones for synthetic peptides of influenza virus hemagglutinin. Heterogeneity of antigen interaction with the T cell and the Ia molecule.
    Mills KH; Burt DS; Skehel JJ; Thomas DB
    J Immunol; 1988 Jun; 140(12):4083-90. PubMed ID: 2453566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overlapping epitopes that are recognized by CD8+ HLA class I-restricted and CD4+ class II-restricted cytotoxic T lymphocytes are contained within an influenza nucleoprotein peptide.
    Carreno BM; Turner RV; Biddison WE; Coligan JE
    J Immunol; 1992 Feb; 148(3):894-9. PubMed ID: 1370522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Broad recognition of cytotoxic T cell epitopes from the HIV-1 envelope protein with multiple class I histocompatibility molecules.
    Shirai M; Pendleton CD; Berzofsky JA
    J Immunol; 1992 Mar; 148(6):1657-67. PubMed ID: 1371784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterizing immunodominant and protective influenza hemagglutinin epitopes by functional activity and relative binding to major histocompatibility complex class II sites.
    Rajnavölgyi E; Horváth A; Gogolák P; Tóth GK; Fazekas G; Fridkin M; Pecht I
    Eur J Immunol; 1997 Dec; 27(12):3105-14. PubMed ID: 9464794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction and activity of class II-restricted, Lyt-2+ cytolytic T lymphocytes specific for the influenza H5 hemagglutinin.
    Hioe CE; Hinshaw VS
    J Immunol; 1989 Apr; 142(7):2482-8. PubMed ID: 2466897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constitutive presentation of dominant epitopes from endogenous naturally processed self-beta 2-microglobulin to class II-restricted T cells leads to self-tolerance.
    Guéry JC; Sette A; Appella E; Adorini L
    J Immunol; 1995 Jan; 154(2):545-54. PubMed ID: 7814867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of class I- and II-restricted T cell recognition of the identical peptide.
    Perkins DL; Berriz G; Wang YS; Smith JA; Gefter ML
    Eur J Immunol; 1991 Nov; 21(11):2781-9. PubMed ID: 1718759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recognition of pre-processed endogenous antigen by class I but not class II MHC-restricted T cells.
    Sweetser MT; Morrison LA; Braciale VL; Braciale TJ
    Nature; 1989 Nov; 342(6246):180-2. PubMed ID: 2478887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytosolic targeting of hen egg lysozyme gives rise to a short-lived protein presented by class I but not class II major histocompatibility complex molecules.
    Calin-Laurens V; Forquet F; Mottez E; Kanellopoulos J; Godeau F; Kourilsky P; Gerlier D; Rabourdin-Combe C
    Eur J Immunol; 1991 Mar; 21(3):761-9. PubMed ID: 2009914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the endoplasmic reticulum in antigen processing. N-glycosylation of influenza hemagglutinin abrogates CD4+ cytotoxic T cell recognition of endogenously processed antigen.
    Thomas DB; Hodgson J; Riska PF; Graham CM
    J Immunol; 1990 Apr; 144(7):2789-94. PubMed ID: 1690778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. I-Ad restricted T cell recognition of influenza hemagglutinin. Synthetic peptides identify multiple epitopes corresponding to antibody-binding regions of the HA1 subunit.
    Barnett BC; Burt DS; Graham CM; Warren AP; Skehel JJ; Thomas DB
    J Immunol; 1989 Oct; 143(8):2663-9. PubMed ID: 2477451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition by chloroquine of the class II major histocompatibility complex-restricted presentation of endogenous antigens varies according to the cellular origin of the antigen-presenting cells, the nature of the T-cell epitope, and the responding T cell.
    Lombard-Platlet S; Bertolino P; Deng H; Gerlier D; Rabourdin-Combe C
    Immunology; 1993 Dec; 80(4):566-73. PubMed ID: 7508420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential recruitment of viral and allo-epitopes into the MHC class I antigen processing pathway of a novel mutant of Ltk- cells. HSV/MHC class I restriction/immune recognition/antigen processing/antigen presentation/influenza virus.
    Lippé R; Kolaitis G; Michaelis C; Tufaro F; Jefferies WA
    J Immunol; 1993 Apr; 150(8 Pt 1):3170-9. PubMed ID: 7682234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of antigen presentation of influenza A nucleoprotein expressed in attenuated AroA- Salmonella typhimurium with that of live virus.
    Brett SJ; Rhodes J; Liew FY; Tite JP
    J Immunol; 1993 Apr; 150(7):2869-84. PubMed ID: 7681081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrasting efficacy of presentation by major histocompatibility complex class I and class II products when peptides are administered within a common protein carrier, self immunoglobulin.
    Zaghouani H; Kuzu Y; Kuzu H; Brumeanu TD; Swiggard WJ; Steinman RM; Bona CA
    Eur J Immunol; 1993 Nov; 23(11):2746-50. PubMed ID: 8223850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific epitope-induced conversion of CD8+ memory cells into effector cytotoxic T lymphocytes in vitro: presentation of peptide antigen by CD8+ T cells.
    Kos FJ; Müllbacher A
    Eur J Immunol; 1992 Jun; 22(6):1595-601. PubMed ID: 1376266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.